<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23">
 <label>23.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Mellado</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Garcia-Effron</surname>
    <given-names>G</given-names>
   </name>, 
   <name name-style="western">
    <surname>Alcázar-Fuoli</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Melchers</surname>
    <given-names>WJG</given-names>
   </name>, 
   <name name-style="western">
    <surname>Verweij</surname>
    <given-names>PE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cuenca-Estrella</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rodríguez-Tudela</surname>
    <given-names>JL</given-names>
   </name>
  </person-group>
  <year>2007</year>
  <article-title>A new 
   <italic>Aspergillus fumigatus</italic> resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations
  </article-title>. 
  <source>Antimicrob Agents Chemother</source>
  <volume>51</volume>:
  <fpage>1897</fpage>–
  <lpage>1904</lpage>. doi:
  <pub-id pub-id-type="doi">10.1128/AAC.01092-06</pub-id>.
  <pub-id pub-id-type="pmid">17371828</pub-id>
 </mixed-citation>
</ref>
